Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/913
Name: Drug, bio-affecting and body treating compositions > Ophthalmic > Glaucoma
Description: Subject matter wherein the ophthalmic disorder is glaucoma.










Patents under this class:
1 2 3 4 5 6 7 8 9 10

Patent Number Title Of Patent Date Issued
6528516 Methods for reducing intraocular pressure using A3 adenosine receptor antagonists Mar. 4, 2003
6511660 Ophthalmic drug delivery formulations and method for preparing the same Jan. 28, 2003
6509332 Methods of treating excessive intraocular pressure Jan. 21, 2003
6500831 Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma Dec. 31, 2002
6458376 Nonaqueous fluorinated drug delivery suspensions Oct. 1, 2002
6458836 Treatment of ocular hypertension and glaucoma Oct. 1, 2002
6455590 Deprenyl compounds for treatment of glaucoma Sep. 24, 2002
6451799 Drugs for ameliorating ocular circulatory disorders Sep. 17, 2002
6444676 Use of PARP inhibitors in the treatment of glaucoma Sep. 3, 2002
6441047 Combination therapy for treating glaucoma Aug. 27, 2002
6426358 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma Jul. 30, 2002
6423321 Cytokine antagonists for the treatment of sensorineural hearing loss Jul. 23, 2002
6419944 Cytokine antagonists for the treatment of localized disorders Jul. 16, 2002
6414021 Control of intraocular pressure during surgery Jul. 2, 2002
6403590 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia Jun. 11, 2002
6387889 Medicinal compositions for treating eye diseases May. 14, 2002
6387910 Drug of improving optic nerve head circulation disorder May. 14, 2002
6384073 Use of macrolide compounds for treating glaucoma May. 7, 2002
6376541 Upregulation of endogenous prostaglandins to lower intraocular pressure Apr. 23, 2002
6359001 Use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes Mar. 19, 2002
6350467 Pharmaceutical preparations of glutathione and methods of administration thereof Feb. 26, 2002
6344485 Method for treating glaucoma Feb. 5, 2002
6342524 Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension Jan. 29, 2002
6331523 Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 Dec. 18, 2001
6329426 Method for treating ocular hypertension of glaucoma Dec. 11, 2001
6329369 Methods of treating pain and other conditions Dec. 11, 2001
6316441 Brinzolamide and brimonidine for treating glaucoma Nov. 13, 2001
6316443 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist Nov. 13, 2001
6300328 Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage Oct. 9, 2001
6297240 Method for treating ophthalmic disease through fast dispersing dosage forms Oct. 2, 2001
6294563 Combinations of prostaglandins and brimonidine or derivatives thereof Sep. 25, 2001
6291529 Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension Sep. 18, 2001
6291506 Method of reducing retinal ganglion cell degeneration Sep. 18, 2001
6288110 Pharmaceutical compositions comprising disulfiram Sep. 11, 2001
6281208 Therapeutic agent for glaucoma Aug. 28, 2001
6274614 Methods, compositions and articles for reducing or preventing the effects of inflammation Aug. 14, 2001
6271224 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia Aug. 7, 2001
6264935 Ophthalmic composition containing a carbonic anhydrase inhibitor and xanthan gum Jul. 24, 2001
6261545 Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders Jul. 17, 2001
6258844 Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents Jul. 10, 2001
6248735 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist Jun. 19, 2001
6242442 Brinzolamide and brimonidine for treating ocular conditions Jun. 5, 2001
6232343 Ophthalmic preparations May. 15, 2001
6194415 Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury Feb. 27, 2001
6172054 Combination therapy for lowering and controlling intraocular pressure Jan. 9, 2001
6166073 Combinations of DP and FP type prostaglandins for lowering IOP Dec. 26, 2000
6159458 Sustained release ophthalmic compositions containing water soluble medicaments Dec. 12, 2000
6159500 Pharmaceutical preparations of glutathione and methods of administration thereof Dec. 12, 2000
6159941 Use of somatostatin agonists and antagonists for treating diseases related to the eye Dec. 12, 2000
6156785 Method for increasing oxygen tension in the optic nerve and retina Dec. 5, 2000

1 2 3 4 5 6 7 8 9 10










 
 
  Recently Added Patents
Method and system for creation and control of virtual rendering devices
Evaporator/absorbers combination, absorption cooling device and associated motor vehicle
Device and method for facilitating the delivery or moving of oversized furniture items
Methods of treatment using ammonia-scavenging drugs
Printing material coating system and method for operating the system
Integrated circuit power management verification method
Display base
  Randomly Featured Patents
Pet habitat with enhanced viewing
Proximity image intensifier
Automatic tone mapping curve generation based on dynamically stretched image histogram distribution
Method and apparatus for automatically adjusting the overshoot of a record head in response to the record head gap depth
Method for fast reinitialization wherein a saved system image of an operating system is transferred into a primary memory from a secondary memory
Defined surfaces of self-assembled monolayers and stem cells
Process for the purification of serum albumin
Passive receivers for wireless power transmission
Tape wiring substrates and packages including the same
Watch